Drugs / bone marrow total nucleated cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02231242 | Sep 2013 → Dec 2015 | cerebral palsy | Hospital Universitario Dr. Jose E. Gonzalez | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bone marrow total nucleated cells | “administration of bone marrow total nucleated cells (TNC) into the brain may produce some benefits by different mechanisms like cytokine production” NCT02231242 ↗ |
| Known as | TNC | “administration of bone marrow total nucleated cells (TNC) into the brain may produce some benefits by different mechanisms like cytokine production” NCT02231242 ↗ |
| Modality | Cell therapy | “autologous bone marrow total nucleated cells” NCT02231242 ↗ |
| Route | Intrathecal | “the autologous TNC concentrate of 10 mL will be infused intrathecally” NCT02231242 ↗ |